Onco-Innovations Limited
ONNVF
$0.78
$0.0913.32%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.58M | -9.02M | -6.55M | -4.85M | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.92M | 4.32M | 2.56M | 2.60M | -- |
| Change in Net Operating Assets | 317.50K | -818.70K | -428.70K | -864.20K | -- |
| Cash from Operations | -4.35M | -5.51M | -4.41M | -3.11M | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 2.80K | 2.80K | 2.80K | 69.40K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.80K | 2.80K | 2.80K | 69.40K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.10K | -9.10K | -9.10K | -9.10K | -- |
| Issuance of Common Stock | 5.99M | 9.36M | 7.51M | 5.80M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -190.80K | -310.90K | -180.20K | -180.20K | -- |
| Cash from Financing | 4.15M | 6.44M | 5.20M | 3.96M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -196.70K | 927.60K | 792.50K | 922.10K | -- |